stocktools
Dilution profile // every instrument, one screen, from SEC filings

10x Genomics, Inc. (TXG)

CIK 1770787 · all EDGAR filings →

Overall dilution risk
HIGHworst of 2 computed signals (offering ability)
= the worst band among the computed sub-ratings, no hidden weighting
not every sub-rating was computable; treat as a floor
Offering ability
HIGHS-3ASR on file 2020-10-16
= is there a registration (S-1/S-3 family) on file without a later withdrawal
no structured fee data on the live registrations, so this is a yes/no, not a size
Overhead supply
NOT COMPUTEDno warrant count tagged in XBRL
= warrant shares outstanding divided by current shares outstanding
absence of a tag is not proof of absence of warrants
Historical dilution
NOT COMPUTEDunder 3 years of share history on file
= share count now vs 3 years ago
Cash need
LOWoperating cash flow positive
= cash vs trailing operating burn (bands: 6mo / 24mo; positive operating CF = low)

Same rating bands the category standard uses, but free, with the formula on the chip and the gaps in the data said out loud.

Shares outstanding over time

Fewer than two cover-page share counts on file, so there is no history to chart.

Cash runway

Self-funding

generates cash

Full breakdown: cash runway tool · source filing →

Warrants

No warrant figures tagged in this filer’s XBRL facts. That means the company has not reported them in structured form; it does not prove no warrants exist. The exhibits are the ground truth.

Convertible notes

No convertible-note facts tagged in the 10-Q filed Aug 7, 2026. If convertible notes exist, their terms live in exhibit prose for this filer and are not parsed; absence of a tag is not proof of absence. The exhibits are the ground truth.

Registrations and offerings

Last 12 months: 0 executed · 0 registered.

REGISTEREDOct 16, 2020Automatic shelf registration — effective immediately (large filers)S-3ASR →
EXECUTEDOct 13, 2020Unregistered share sale disclosed (8-K item 3.02)8-K →
EXECUTEDOct 5, 2020Unregistered share sale disclosed (8-K item 3.02)8-K →
EXECUTEDSep 11, 2020Final prospectus — offering priced (typical for IPOs and marketed share deals)424B4 →
REGISTEREDSep 10, 2020S-1MEF registration — capacity to sell shares, not a sale yetS-1MEF →
EFFECTIVESep 10, 2020SEC declared a registration effective — selling can beginEFFECT →
REGISTEREDSep 8, 2020S-1 registration — capacity to sell shares, not a sale yetS-1 →
UPDATESep 27, 2019Prospectus update — often a resale registration, not necessarily new capital424B3 →
MARKETINGSep 12, 2019Free-writing prospectus — offering being marketedFWP →
EXECUTEDSep 12, 2019Final prospectus — offering priced (typical for IPOs and marketed share deals)424B4 →
REGISTEREDSep 11, 2019S-1MEF registration — capacity to sell shares, not a sale yetS-1MEF →
EFFECTIVESep 11, 2019SEC declared a registration effective — selling can beginEFFECT →

Full history and shelf status: offering checker · S-3 shelf checker

Source: SEC EDGAR XBRL company facts and filing metadata, fetched live and cached briefly. Share counts are cover-page figures with their form named. Warrant tranches and convertible notes come from the dimensioned facts in the latest 10-Q/10-K instance document, exactly as the company tagged them; untagged tranches and notes are absent, not disproven. Nothing on this page is manually verified and nothing is behind a login: what free data supports is shown, what it cannot support is stated. Not investment advice.

Keep going: float checker · offering calendar · short-squeeze screener · full TXG workspace